Clinical Trials in Ohio

Showing 15421-15440 of 20,938 trials

Clinical Evaluation of Approved Contact Lenses

NCT02699593

This is a 4-week, randomized, double-masked study where subjects will wear bilaterally test and control lenses in random succession. The objective is to evaluate materials from different suppliers.

Visual Acuity

Johnson & Johnson Vision Care, Inc.142 participantsStarted Feb 2016

Birmingham, Alabama, United States • Jacksonville, Florida, United States • Sarasota, Florida, United States +4 more locations

UNKNOWNPhase 132 miles

Natreon Healthy Skin Study - PrimaVie Supplement

NCT02762032

This study will demonstrate the ability of the oral supplement, PrimaVie® to improve skin microperfusion, hydration, elasticity and barrier function. 45 females will be enrolled in 1 of 3 arms where they will receive either 125 mg PrimaVie, 250 mg PrimaVie or placebo (control) to take twice daily for 14 weeks.

Healthy

Ohio State University45 participantsStarted Feb 2016

Columbus, Ohio, United States • Columbus, Ohio, United States • Columbus, Ohio, United States

COMPLETED32 miles

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

NCT00437060

This clinical trial is looking at brain function in young patients receiving methotrexate for acute lymphoblastic leukemia. Learning about the long-term effects of methotrexate on brain function may help doctors plan cancer treatment.

Childhood B Acute Lymphoblastic LeukemiaChildhood T Acute Lymphoblastic LeukemiaCognitive Side Effects of Cancer Therapy+4 more

Children's Oncology Group233 participantsStarted Jan 2007

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Downey, California, United States +109 more locations

Clinical Evaluation of Approved Contact Lenses

Natreon Healthy Skin Study - PrimaVie Supplement

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

Find Trials by Condition in Ohio

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)

A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects

Mastectomy Reconstruction Outcomes Consortium (MROC) Study

Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database

Telephone Support to Improve Adherence to Anti-HIV Medications

Pediatric Cefazolin PK Study

A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer

Spinal Cord Stimulation for Predominant Low Back Pain

Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds

A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832)

Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.

Partnership for Rapid Elimination of Trachoma

Study of Diclofenac Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age

Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer

Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer